Announcement on Adjusting Upper Limit of Shares Repurchase Price
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Adjusting Upper Limit of Shares Repurchase Price
Filed with SSE · · 3 pages · Chinese
Release
Earlier from RemeGen
- Announcement on Signing a Licensing Agreement with AbbVie
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Canceling Some Restricted Stock Granted but Not Yet Vested in 2022 A-share Restricted Stock Incentive Plan
- Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution
- Announcement on Resolutions of the 32nd Meeting of the 2nd Board of Directors
Later from RemeGen
- Announcement on Completion of Initial Share Repurchase and Implementation of Share Repurchase Plan
- Announcement on Vesting Results of Relevant Rights in the Related Vesting Period of the 2022 and 2023 A-share Restricted Stock Incentive Plans and Shares Listing
- Earnings Preannouncement for 2025
- Announcement on Changing Signatory Certified Public Accountant
- Announcement on Voluntary Disclosure of Approval of Marketing Application for Vedicizumab the Treatment of HER2-Low Expressing Breast Cancer with Liver Metastasis
Follow RemeGen into a list and get an email when it puts out news.
Follow RemeGen